Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Cabaletta Bio Inc (NQ: CABA ) 7.190 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Jul 22, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open 7.190 Bid (Size) 6.900 (2) Ask (Size) 7.300 (2) Prev. Close 7.190 Today's Range 7.190 - 7.190 52wk Range 6.830 - 26.35 Shares Outstanding 31,355,723 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Cell Therapy Mostly Used For Blood Cancer Shows Efficacy In Autoimmune Diseases As Well, But There Are Challenges July 19, 2024 CAR-T therapy, originally used for blood cancers, shows promising results in treating lupus, as evidenced by Janina Paech's remarkable remission. This breakthrough offers new hope for autoimmune... Via Benzinga Cabaletta Bio to Participate in the Stifel 2024 Virtual Cell Therapy Forum July 02, 2024 From Cabaletta Bio Via GlobeNewswire Performance YTD -67.55% -67.55% 1 Month -13.89% -13.89% 3 Month -46.02% -46.02% 6 Month -64.88% -64.88% 1 Year -42.85% -42.85% More News Read More Why Kaival Brands Innovations Shares Are Trading Lower By 47%? Here Are Other Stocks Moving In Friday's Mid-Day Session June 21, 2024 Via Benzinga Recap: Cabaletta Bio Q4 Earnings March 21, 2024 Via Benzinga Cabaletta Bio Inc. (NASDAQ: CABA) is a Stock Spotlight on 12/8 December 08, 2023 Via Investor Brand Network Asana, Clover Health Investments, Hertz Global And Other Big Stocks Moving Higher On Friday June 21, 2024 Via Benzinga Why Quantum Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session June 18, 2024 Via Benzinga Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session June 14, 2024 Via Benzinga Cabaletta Bio Reports Positive Initial Clinical Data from Phase 1/2 RESET-Myositis™ and RESET-SLE™ Trials of CABA-201 June 14, 2024 From Cabaletta Bio Via GlobeNewswire Cabaletta Bio to Participate in the Jefferies Global Healthcare Conference May 29, 2024 From Cabaletta Bio Via GlobeNewswire CABA Stock Earnings: Cabaletta Bio Misses EPS for Q1 2024 May 15, 2024 Via InvestorPlace NEXTracker Posts Upbeat Earnings, Joins monday.com, Nu Holdings And Other Big Stocks Moving Higher On Wednesday May 15, 2024 Via Benzinga Why Bolt Biotherapeutics Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session May 15, 2024 Via Benzinga Cabaletta Bio Reports First Quarter 2024 Financial Results and Provides Business Update May 15, 2024 From Cabaletta Bio Via GlobeNewswire Cabaletta Bio to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ May 13, 2024 From Cabaletta Bio Via GlobeNewswire CABA Stock Earnings: Cabaletta Bio Misses EPS for Q4 2023 March 21, 2024 Via InvestorPlace Cabaletta Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update March 21, 2024 From Cabaletta Bio Via GlobeNewswire Cabaletta Bio Announces FDA Granted Orphan Drug Designation to CABA-201 for Treatment of Systemic Sclerosis March 20, 2024 From Cabaletta Bio Via GlobeNewswire Cramer: This REIT Is 'A Little Too Dicey'; As For Marathon Digital, 'Own The Pure' March 06, 2024 Via Benzinga Cabaletta Bio to Participate in Upcoming Investor Conferences in March February 27, 2024 From Cabaletta Bio Via GlobeNewswire Cabaletta Bio Announces FDA Granted Orphan Drug Designation to CABA-201 for Treatment of Myositis February 01, 2024 From Cabaletta Bio Via GlobeNewswire Cabaletta Bio to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference January 31, 2024 From Cabaletta Bio Via GlobeNewswire 12 Health Care Stocks Moving In Monday's After-Market Session January 22, 2024 Via Benzinga Cabaletta Bio Receives Additional FDA Fast Track Designations for CABA-201 in Dermatomyositis and Systemic Sclerosis January 08, 2024 From Cabaletta Bio Via GlobeNewswire Cabaletta Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference January 02, 2024 From Cabaletta Bio Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
